Amneal Pharmaceuticals, Inc. AMRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 38.7%+1.8pp | 36.9%+0.1pp | 36.8%-0.9pp | 37.7%+1.0pp | 36.7%+0.2pp | |
| Operating margin | 14.3%+1.2pp | 13.1%+0.9pp | 12.2%-1.0pp | 13.2%+0.5pp | 12.7%+3.8pp | |
| Net margin | 4%+1.6pp | 2.4%+2.2pp | 0.2%+0.1pp | 0.1%+0.6pp | -0.5%+3.7pp | |
| Free cash flow margin | 7.9%-1.0pp | 8.9%-0.1pp | 9%-0.9pp | 9.9%+1.0pp | 8.9%+0.2pp | |
| Returns | ||||||
| Return on assets | 3.5%+1.5pp | 2%+1.8pp | 0.2%+0.1pp | 0.1%+0.5pp | -0.4%+3.0pp | |
| Return on invested capital | 20.1%+4.4pp | 15.7%+2.3pp | 13.4%+3.3pp | 10.1%+0.7pp | 9.4%-1.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Inventory turnover | 3×-0.1× | 3.1×+0.1× | 3.1×+0.1× | 3×-0.1× | 3.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.3× | 2.2×0.0× | 2.1×+0.7× | 1.4×0.0× | 1.4×0.0× | |
| Quick ratio | 1.6×+0.1× | 1.5×+0.1× | 1.4×+0.5× | 0.9×0.0× | 0.8×0.0× | |
| Cash ratio | 0.3×0.0× | 0.3×+0.1× | 0.2×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-assets | 0.7×0.0× | 0.7×0.0× | 0.7×+0.1× | 0.6×0.0× | 0.6×-0.1× | |
| Per Share | ||||||
| Book value per share | -$0.14+36.7% | -$0.22+35.3% | -$0.34+3.1% | -$0.35+14.4% | -$0.41-14.9% | |
| Valuation | ||||||
| Market capitalization | $3.97B+0.1% | $3.96B+26.0% | $3.14B+23.4% | $2.55B-3.0% | $2.63B+7.0% | |
| Enterprise value | $6.34B-0.5% | $6.37B+15.4% | $5.52B+18.5% | $4.65B-2.1% | $4.75B-1.7% | |
| Price / earnings | 32.5×— | —— | —— | —— | —— | |
| Price / sales | 1.3×0.0× | 1.3×+0.2× | 1.1×+0.2× | 0.9×0.0× | 0.9×0.0× | |
| EV / sales | 2.1×0.0× | 2.1×+0.2× | 1.9×+0.2× | 1.6×0.0× | 1.7×-0.1× | |
| Free cash flow yield | 6.1%-0.7pp | 6.8%-1.6pp | 8.4%-2.7pp | 11.1%+1.5pp | 9.6%-0.4pp | |
| Earnings yield | 3.1%+1.3pp | 1.8%+1.6pp | 0.2%+0.1pp | 0.1%+0.6pp | -0.5%+4.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s profit margins?
- Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
- Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.